Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ziyi Qiu
Institutions:
Qilu Hospital of Shandong University,
Nanjing Medical University
Observed institutions:
Shandong University,
Qilu Hospital of Shandong University,
Nanjing Medical University
ORCID:
0009-0009-8513-3200
Observed ORCID:
0009-0009-8513-3200
OpenAlex ID:
A5041919308
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
2023
·
Lina Wei
, Xiaohong Ma
, et al.
·
Cell Death Discovery
·
41
PDF
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis
2025
·
Rui Sun
, Ying Zhao
, et al.
·
Cell Death and Disease
·
26
PDF
Novel insights into tumorigenesis and prognosis of endometrial cancer through systematic investigation and validation on mitophagy-related signature
2023
·
Rui Sun
, Xiaoyu Zhou
, et al.
·
Human Cell
·
8
Gut Microbiota and Their Metabolites in Acute Kidney Injury: Classification, Mechanisms, and Therapeutic Potential
2026
·
Ziyi Qiu
, Hao Zhang
, et al.
·
Metabolites
The metabolic‐immune hub: Dual roles of indoleamine 2,3‐dioxygenase in the acute kidney injury‐to‐chronic kidney disease transition and therapeutic perspectives
2026
·
Ziyi Qiu
, Binbin Pan
·
Clinical and Translational Discovery
Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening
2026
·
Xinyue Li
, Shourong Wang
, et al.
·
Scientific Reports
PDF
Show more works
View as search
Works count:
6
Citation count:
75
H-index:
3
I10-index:
2
Year
Topic
Type